Tutorials
Caribou Biosciences Inc logo

Caribou Biosciences Inc

$ 9.91 +0.52 (+5.54%) 08:09 PM EST
P/E:
At Loss
P/B:
1.73
Market Cap:
$ 602.93M
Enterprise V:
$ 290.98M
Volume:
413.62K
Avg Vol (2M):
610.36K
Volume:
413.62K
Market Cap $:
602.93M
PE Ratio:
At Loss
Avg Vol (2-Month):
610.36K
Enterprise Value $:
290.98M
PB Ratio:
1.73
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Caribou Biosciences Inc
NAICS : 541713 SIC : 2833
2929 7th Street, Suite 105, Berkeley, CA, USA, 94710
Description
Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 12.15
Equity-to-Asset 0.83
Debt-to-Equity 0.08
Debt-to-EBITDA -0.32
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.74
Distress
Grey
Safe
Beneish M-Score -1.24
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate Industry Rank 16.05

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 85.67
9-Day RSI 80.02
14-Day RSI 74.2
6-1 Month Momentum % -37.16
12-1 Month Momentum % -71.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.23
Quick Ratio 12.23
Cash Ratio 11.78
Days Sales Outstanding 14.34

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-11-09 Est.)

CRBU's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CRBU

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 13.392
EPS (TTM) ($) -1.53
Beta 0
Volatility % 107.17
14-Day RSI 74.2
14-Day ATR ($) 0.621001
20-Day SMA ($) 8.198
12-1 Month Momentum % -71.03
52-Week Range ($) 4.89 - 32.645
Shares Outstanding (Mil) 60.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Caribou Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More